Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review

Overview of attention for article published in Frontiers in oncology, September 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 18,721 followers.

RT @FrontOncology: New research: Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous…

21 Sep 2023

Reply Repost Favourite

New research: Osimertinib inhibits brain metastases and improves long-term survival in a patient with advanced squamous cell lung cancer: a case report and literatures review: Background Squamous cell carcinoma (SCC) is one of the most common… #oncology h

21 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.